Medicare is about to let some people get GLP-1 weight-loss drugs for $50 a month. That sounds simple. This is American healthcare, so naturally, there is a bridge, a toll booth, several eligibility signs, and a pharmacist trying to find the right billing code. For the past few years, the GLP-1 weight-loss drugs story has mostly sounded like this: A patient hears about Wegovy or Zepbound. A doctor agrees it may help. The patient walks to the pharmacy. The pharmacy says somethi

Explore Medicare's groundbreaking decision to negotiate Ozempic pricing in PoundsPunch Periodical 2025.01.

Biden’s Weight-Loss Drug Proposal Faces Trump-Era Challenges, Ireland’s Crackdown on Counterfeits, and China’s Next-Gen GLP-1 Innovations

Commercial Insurance Dominated Weight Loss Prescriptions, Medicare May Target Wegovy for Price Cuts, FDA Reported Eased Drug Shortages